Glutaric Aciduria type II a Fatty acid oxidation defect

Slides:



Advertisements
Similar presentations
DIABETIC KETOACIDOSIS. Diabetes Mellitus {sugar diabetes} An ancient disease Names in ancient times by Greek physicians The noted that those with diabetes.
Advertisements

In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Block 9 Board Review Endocrine/Rheum 14Feb14 Chauncey D. Tarrant, M.D. Chief of Residents
Canadian Diabetes Association Clinical Practice Guidelines Hyperglycemic Emergencies in Adults Chapter 15 Jeannette Goguen, Jeremy Gilbert.
Approach to Inborn Error of Metabolism in a Neonate Filomena Hazel R. Villa, MD PL2.
Lactic Acidosis Dr. Usman Ghani 1 Lecture Cardiovascular Block.
1-800-DIABETES DIABETES CARE TASKS AT SCHOOL: What Key Personnel Need to Know DIABETES CARE TASKS AT SCHOOL: What Key Personnel Need to.
Chapter 11 Newborn Screening. Introduction Newborns can be screened for an increasing variety of conditions on the principle that early detection can.
Diarrhea Dr. Adnan Hamawandi Professor of Pediatrics.
Clinical Case 3. A 14 year old girl was brought to her GP’s office, complaining of: – weight loss, – dry mouth, – lethargy, – easy fatigability – and.
Hypoglycemia Paolo Aquino 29 January Overview of hypoglycemia  What is it?  Why do we care about it?  What causes it?  How do we diagnose it?
Kidney Function Tests Rana Hasanato, MD, KSFCB
Pediatric Fluid Therapy Dr. Radi M. A
Parenteral nutrition in neonate. Goals minimizes weight loss improves growth and neurodevelopmental outcome reduce the risk of mortality and NEC.
MAPLE SYRUP URINE DISEASE (MSUD) IS A METABOLISM DISORDER PASSED DOWN THROUGH FAMILIES IN WHICH THE BODY CANNOT BREAK DOWN CERTAIN PARTS OF PROTEINS. URINE.
Fluids and Electrolytes
ED Board Questions Tamara Gayle, MD PGY-1. A 4 year old girl who has the classic form of Maple Syrup Urine Disease is brought to the emergency department.
Pregnancy & Newborn Screening Developments Medium Chain Acyl CoA Dehydrogenase Deficiency (MCADD)
H1N1 General Information Update Karen Dahl, MD Pediatric Infectious Diseases.
Diabetes Mellitus Type 1
Diabetic Ketoacidosis DKA)
Management of diabetic ketoacidosis and hypoglycemia Prof. Hanan Hagar.
DIABETIC ATHLETES Sports Injury Management. There are two types of diabetes. Type I: deficiency of insulin Type I is treated with insulin (injections,
Assistant Professor of Clinical Pharmacy
Endocrine Disorders in the Pediatric Client Susan Beggs, MSN, CPN Susan Beggs, MSN, CPN.
ACUTE COMPLICATIONS. 18 years old diabetic patient was found to be in coma What questions need to be asked ? Differentiating hypo from hyperglycemia ?
KETONE BODY METABOLISM Dr.Siddiqui Abdulmoeed Associate Professor of Biochemistry College of Medicine Al-jouf University.
Adult Medical-Surgical Nursing Endocrine Module: Acute Complications of Diabetes Mellitus.
Parenteral Nutrition By Dr. Hanan Said Ali. Objectives. Define parenteral nutrition. Explain how to prepare the patient. Explain how administer parenteral.
Fatty Acid Oxidation Defects
DIABETIC KETOACIDOSIS By, Dr. ASWIN ASOK CHERIYAN Chair Person – Dr. JAYAMOHAN A.S.
Management of diabetic ketoacidosis Prof. M.Alhummayyd.
Fluid Therapy 24 April, 2009 review. Ⅰ Ⅰ fluid balance in child 1. The total amount of body fluids in children : The younger, The younger, the greater.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.
Management of diabetic ketoacidosis (DKA) Prof. M.Alhummayyd.
Hyperglycemic Emergencies Dr. Miada Mahmoud Rady Ems/474 Endocrinal Emergencies Lecture 3.
Diabetic Ketoacidosis.  An anion gap acidosis due to severe insulin deficiency and excess of counterregulatory hormones.
Diabetic Ketoacidosis (DKA) Mona Omran, Jung Eun Lee, Tiffany Ou, Annie Yan PHM142 Fall 2015 Coordinator: Dr. Jeffrey Henderson Instructor: Dr. David Hampson.
Acute Renal Failure Doç. Dr. Mehmet Cansev. Acute Renal Failure Acute renal failure (ARF) is the rapid breakdown of renal (kidney) function that occurs.
Diabetic Ketoacidosis DKA PHCL 442 Lab Discussion 6 Raniah Al-Jaizani M.Sc.
Treatment of Metabolic Acidosis in CKD Presented by Pharmacist: Ola Mohammad Elkersh PharmD student
Aspirin Toxicity.
MANAGEMENT. General Initial Management 1.assessment and control of the airways and of ventilation, 2.ABG, ECG and blood pressure monitoring. 3.Other measures.
Endocrine System KNH 411. Diabetes Mellitus 7% of population; 1/3 undiagnosed $132 billion in health care Sixth leading cause of death Complications of.
 Hypoglycemia  Physical Signs  –Sweating  –Tremulousness  –Tachycardia  –Respiratory Distress  –Abdominal Pain  –Vomiting.
DIABETIC KETOACIDOSIS Emergency pediatric – PICU division H. Adam Malik Hospital – Medical School University of Sumatera Utara 1.
Management of diabetic ketoacidosis and hypoglycemia Prof. Hanan Hagar.
Oxidation of Fatty Acid
Management of diabetic ketoacidosis and hypoglycemia
Maintenance and Replacement Therapy
Nutrition in glutaric acidemia
WAN NUR SHAMIMI BINTI WAN ZAHARI D11B045
DKA TREATMENT GUIDELINES.
ACUTE COMPLICATIONS.
Nutrition Management of Maple Syrup Urine Disease
ACUTE COMPLICATIONS.
Management of diabetic ketoacidosis
Endocrine System KNH 411.
Management of diabetic ketoacidosis and hypoglycemia
Endocrine Emergencies & Management
Endocrine System KNH 411.
Endocrine System KNH 411.
Fluid Balance, Electrolytes, and Acid-Base Disorders
A.S. Grice, T.E. Peck  British Journal of Anaesthesia 
Endocrine System KNH 411.
Endocrine System KNH 411.
Endocrine System KNH 411.
Lactic Acidosis Cardiovascular Block.
Aspirin & NSAID.
Endocrine Emergencies
Presentation transcript:

Glutaric Aciduria type II a Fatty acid oxidation defect NORAH A A KHATHLAN MD Consultant Pediatric Intensivist Director PICU 04/ 2007 GA II

Glutaric Aciduria type II GA II

Glutaric Acid It is an intermediate in three major metabolic pathways: -Fatty acid metabolism -Lysine metabolism -Tryptophan metabolism GA II

Fatty acid oxidation defects Short chain acyl-CoA dehydrogenase def. (SCAD) Medium chain acyl-Co A dehydrogenase def. (MCAD) Long chain acyl-CoA dehydrogenase def. (LCAD) Multiple acyl-CoA dehydrogenase def. (MAD) Riboflavin responsive defects of ß-oxidation (RR-MAD) 3-Hydroxy-3-methylgtutaryl CoA lyase def. (HMG-CoA) GA II

MAD deficiencies Defects in electron transfer flavoprotein ( ETF ) & its dehydrogenase (ETF-DH). Impairs transfer of electrons into mitochondria electron transfer chain. 2 Types: (MAD-S) severe neonatal form or. GLUTARIC ACIDURIA type II. ( MAD- M) mild “late onset” variant. ethyl-malonic-adipic aciduria. GA II

Glutaric aciduria II ( MAD-S ) Severe neonatal form: acidosis, hypoglycemia, coma, hypotonia & cardiomyopathies. Two subgroups: With congenital anomalies. 2. Without congenital anomalies. GA II

Clinical picture Growth retardation. Special odor. Metabolic acidosis. Hypoglycemia. Dysmorphism. Early neonatal death. Def of electron transport chain flavoprotein or its oxidoreductase. GA II

( MAD- S ) Abnormal liver (including function) Biliary atresia & stenosis Macrocephaly Large kidneys & Multiple renal cysts Organic aciduria Pancreas (exocrine), general abnormalities Undermineralization of skull GA II

( MAD- S ) Macrocephaly. Brain, general abnormalities. Club foot/hindfoot, varus. Rocker-bottom feet / hindfeet. Fontanelles, delayed closure/large. Hamartoma of brain. Hypoglycaemia. Hypospadias. GA II

Diagnosis Urinary organic acid profile. GCMS Shows - Ethyl-malonic acid - Dicarboxylic acid - Lysine - Branched chain amino acid Blood metabolic screening : Tandem MS - Glutaric acid - Lysine - Leucine GA II

Glutaric aciduria type II Differentiate from GA type I. Def. Of glutaryl CoA dehydrogenase. Progressive dystonia & dyskinesia. Vomiting , seizures, coma & Reye-like presentation. Ketosis, hypoglycemia, hyperammonemia & hepatitis picture. High conc of glutaric acid in serum & urine.  3- Hydroxyglutaric acid. C.F. 2- Hydroxyglutaric acid in GA II. N.B. Glutaric aciduria type III is a peroxisomal disorder.Very long chain fatty acids GA II

Treatment Acute illnesses : Chronic: Prompt treatment with D10% to suppress lipolysis. Correct acidosis. Chronic: Avoid starvation. Special formula. (low protein-low fat). Carnitine & riboflavin supplements. GA II

Sick days plan for patients with G.A. II Problems that may lead to significant metabolic illnesses in children with organic acidemias: Fever - increases metabolic rate, increases rate of protein breakdown and dehydration. Painful infections - Pain increases metabolic rate, infections of the mouth and throat often decrease appetite and fluid intake. GA II

Sick days plan for patients with G.A. II 3. Vomiting - prevents calorie and fluid intake and may be a sign of metabolic illness. 4. Diarrhea - causes dehydration, sodium and bicarbonate loss, and acidemia - all of which decrease the ability of the liver and kidney to remove pathological metabolites from the blood. GA II

Sick days plan for patients with G.A. II 5. Poor appetite - when calorie intake falls below 45 Cal/kg-day, then protein from muscle is broken down for energy . When a sustained increase in protein catabolism is combined with dehydration and acidemia , then the catabolic state is associated with brain intoxication and injury. GA II

Goals of treatment during illnesses: Metabolic illnesses usually evolve over a 12-48 hour period. Early recognition of illness or the problems listed above and careful attention to specific goals of treatment will usually keep the metabolic disorder under control. If the goals are not met and signs of illness develop then evaluation at hospitalization for emergency management may be necessary. GA II

Goals of treatment during illnesses: Minimum daily caloric intake 60 Cal/kg-day. If eating is poor then give small amounts regularly every 2 hours. GA II

Goals of treatment during illnesses: 3. If fever is high and diarrhea is frequent then weigh twice daily, A weight loss of more than 3-5% is significant in an infant with such disorders. 4. Treat fever and pain with high doses of Tylenol 130 mg every 4 hours as needed to keep fever under 38°C. GA II

In-hospital management of acute illnesses Successful therapy in part depends upon : continued infusion of glucose at a rate of approximately twice the basal metabolic rate of the patient. an initial insulin response to rapid glucose administration. GA II

In-hospital management of acute illnesses cont. If hyperglycemia (>200 mg/dl) persists beyond the first 120 minutes of therapy then regular insulin should be administered by IV bolus starting at 0.1 units/kg. Insulin should be used to maintain the blood glucose between 100-150 mg/dl and should be discontinued when the blood glucose falls below 100 mg/dl. GA II

In-hospital management of acute illnesses “Hyperglycemia should not be considered an indication for lowering the rate of glucose infusion, to do so defeats the purpose of the therapy.” GA II

In-hospital management of acute illnesses Acidemia also must be managed aggressively. Recovery may depend in part upon the renal clearance of non-volatile dicarboxylic acids. correction of acidemia, intravascular volume expansion to establish vigorous urine output (initial bolus 20 ml/kg), and a urine pH greater than 7.5. During correction of acidemia blood potassium may decrease, to allow urine alkalization potassium should be maintained 3.5 - 4.5 mEq/L, which can usually be accomplished with 10-20 mEq/L KCL in the IV fluid. GA II

Pitfalls If a metabolic disorder is still suspected with a negative screening  repeat Tandem MS & request GCMS. Do not lower the glucose infusion rate due to hyperglycemia….! Give insulin. Minimal protein “TPN” helps to control catabolism. GA II

THANK YOU GA II